The prevalence and demographic determinants of blood donors receiving testosterone replacement therapy at a large USA blood service organization.
Kelsey HazeghMarjorie D BravoHany KamelLarry DumontTamir KaniasPublished in: Transfusion (2020)
TRT is associated with high prevalence of erythrocytosis and obesity that may explain the intensive donation frequency, high MAP, and Hb. Frequent phlebotomies had a moderately positive effect on blood pressure and Hb levels. Potential implications of TRT on the quality of the RBC products require further evaluation.